Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19 (HoCoPsy)
Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in Pandemic and Confinement Context
The actual worldwide context (disease outbreak, confinements instaured in many countries) is a stressful factor for many people. It can have consequences on mental health : separation from loved ones, loss of freedom, uncertainty about infection status, boredom. Patients with mental disorders are especially vulnerable.
On march 17th, the french government ordonned a national confinement to slow the progression of the COVID-19 outbreak, for 15 days at first then renewed several times. This situation has led to a reorganization of care as requested on March 22nd, 2020 in the recommendations applicable to the organization of care in psychiatric services : priority to telephone contacts and teleconsultation by multiplying contacts and assessments.
By the time the reorganization of care became operational, the most vulnerable patients may have experienced a decompensation of their disease.
It is important to know if the COVID-19 outbreak combined with the confinement increased the number of unvoluntary commitment the month after the announce of the confinement.
This could help us understand which patients are more vulnerable is this context, and improve our organization (ambulatory and hospitalization care) if this situation occurs again.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
The main objective is to notice if we can observe a increase in the number of unvonluntary commitment the month after the announce of the confinement in the psychiatric hospital La Colombière, CHU Montpellier, France.
Secondary objectives :
- Describe the causes of unvonluntary commitment, and the principal psychiatric diagnostic of the patients
- Assess the lengh of the hospitalization
- Assess the number of patients hospitalized without psychiatric antecedent
- Assess the number of treatment interruptions in the recent history before hospitalization
- Asses the number of patients living alone
- Asses the number of patients using drugs
It is expected to highlight :
- An increase of the number of unvontuntary commitment
- If one or several mental disorders were more at risk of requiring an unvonluntary commitment
- An increased lengh of hospitalization
- An increased number of unvonluntary commitment of patients without psychiatric antecedent
- An increased number of treatment interruptions
- A link between hospitalization and living alone
- A link between hospitalization and using drugs
The medical file of all the patients unvonlutary commited from march 12th to April 09th 2020 are screened, and compared to the patients unvonlutary commited during the same period in 2019.
The caracteristics of interest are their age and sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Montpellier, Frankrike, 34295
- University Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion criteria:
- Unvonluntary commitment in psychiatric hospital La Colombière, CHU Montpellier, from march 12th to april 19th (2019 and 2020).
Exclusion criteria:
- refusal to participate
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Unvonluntary commitment from March 12th to April 09th 2019
Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2019
|
Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.
|
|
Unvonluntary commitment from March 12th to April 09th 2020
Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2020
|
Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of hospitalized patients
Tidsramme: 1 months
|
Number of hospitalized patients From March 12th to April 09th
|
1 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Cause of hospitalization
Tidsramme: 1 months
|
Primary psychiatric diagnostic From March 12th to April 09th
|
1 months
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Lengh of hospitalization
Tidsramme: 1 months
|
Patients without psychiatric antecedent (number) From March 12th to April 09th
|
1 months
|
|
Treatment interruption
Tidsramme: 1 months
|
Presence of absence of history of treatment interruption leading to the hospitalization From March 12th to April 09th
|
1 months
|
|
Number of hospitalized patients living alone
Tidsramme: 1 months
|
Number of hospitalized patients living alone (opposed to those living with family) From March 12th to April 09th
|
1 months
|
|
Use of drugs
Tidsramme: 1 months
|
Number of patients using drugs From March 12th to April 09th
|
1 months
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Emilie OLIE, MD PhD, University Hospital, Montpellier
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- RECHMPL20_0320
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .